The United States has approved Pfizer and Modern Covid Ticker booster doses for everyone over the age of 18. The U.S. Drug Enforcement Administration gave this approval on Friday, local time. The country has taken this step amid fears of a new wave of epidemics in the coming winter. News agency AFP.
The United States has previously approved bovid tick booster doses. In this case, people with low immunity, over 65 years of age, high risk of serious diseases, and high-risk occupants could take Bovid Ticker Booster Doses in the country for so long.
Announcing the approval of the booster dose of the vaccine on Friday, Janet Woodcock, acting commissioner of the US Food and Drug Administration (FDA), said: “This decision will help provide long-term protection against corona. Particularly dire consequences, such as hospitalization and death. ‘
An expert panel from the US Centers for Disease Control and Prevention (CDC) has recommended that all adults be given a ticker booster dose. The panel’s recommendation will now be formally approved by CDC Director Rochelle Welensky on giving booster doses to all adults.
The FDA said in a statement that the decision was based on evidence that hundreds of people had developed strong immune systems in booster doses of Moderna and Pfizer.
Pfizer conducted a booster dose clinical trial of 10,000 people over the age of 18. It found that the booster dose was 95 percent more effective than the usual dose for covid patients with symptoms. The booster dose should be taken six months after the first two doses of the vaccine.
Adult booster doses have been approved in the United States, with 6,000 new corona diagnoses per day. The United States is said to be the epicenter of the fifth wave of epidemics. Corona has already killed more than 6 lakh people in the worst-hit country.